Evidence map›Paper›PMID 12010983›Full record

ArticleInfection and immunity2002

Antigen-presenting cell function during Plasmodium yoelii infection.

James Luyendyk, O Renee Olivas, Lisa A Ginger, Anne C Avery

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Innate immunity to malaria.Nature reviews. Immunology · 2004
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

James LuyendykDepartment of Pharmacology and Toxicology, Institute for Environmental Toxicology, National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan 48824, USA.
O Renee Olivas
Lisa A Ginger
Anne C Avery
Colorado State University · USMichigan State University · US

Funding

ANTIGEN PRESENTATION IN MALARIA INFECTIONR01AI042354 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI AVERY, ANNE C · 1999 to 2002
$757k
NIAID NIH HHS AI-42354NIAID NIH HHS R01 AI042354
6 · The paper itself

Abstract

Antigen-presenting cells (APC) play a key role in orchestrating immune responses. T-cell proliferative responses are inhibited during the erythrocyte stages of malaria infection, and a number of studies have suggested that APC are responsible for this phenomenon. In the present studies we examine individual components of the T-cell-activating function of APC: expression of costimulatory and major histocompatibility complex (MHC) class II proteins, the ability to process and present antigen to T cells, and the ability to support cytokine production. We find that during the acute phases of Plasmodium yoelii erythrocyte stage infection, APC upregulate the expression of class II MHC and CD80, maintain expression of CD86, process and present antigen, and support gamma interferon production. However the CD11b(+) subpopulation produces a soluble factor or factors that specifically inhibit interleukin-2 (IL-2) production by responding CD4 T cells. This factor is distinct from prostaglandin E(2), NO, or transforming growth factor beta. The data suggest that IL-2 suppression observed during malaria infection is not due to functional defects of APC but is triggered by production of a factor(s) that actively suppresses production of IL-2 by T cells.

Indexed as

AnimalsAntigen-Presenting CellsAntigens, CDB7-1 AntigenB7-2 AntigenCell DivisionCells, CulturedDinoprostoneDisease Models, AnimalFemaleHistocompatibility Antigens Class IIInterferon-gammaInterleukin-2MalariaMembrane GlycoproteinsMiceAntigens, CDB7-1 AntigenB7-2 AntigenCd86 protein, mouseDinoprostoneHistocompatibility Antigens Class IIInterferon-gammaInterleukin-2Membrane GlycoproteinsNitric OxideTransforming Growth Factor beta

Identifiers

PMID12010983
PMCPMC128011
OpenAlexW2150133540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.